C4 Therapeutics, Inc
Veridion Score
BETALOW CONF · 4/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is CCCC moving today?
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
CCCC overview
Related filings and maps
Congress activity in CCCC
No receipt-qualified Congressional disclosure is present for CCCC in the cached public ledger.
CCCC contract awards, year to date.
Public federal awards linked to this ticker.
CCCC lobbying filings, year to date.
Registered lobbying filings matched to C4 Therapeutics, Inc.